Evogene Ltd. (EVGN) Misses Q2 EPS by 1c

Evogene Ltd. (NYSE: EVGN) reported Q2 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $2.66 million versus the consensus estimate of $4.4 million.

For earnings history and earnings-related data on Evogene Ltd. (EVGN) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Largo restructures $82.2M in debt, extending maturity to 2030
• Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue